An ABC of drug-related problems, Drug Saf, vol.22, pp.415-423, 2000. ,
, World Health Organization. The importance of pharmacovigilance-Safety monitoring of medicinal products. Geneva: World Health Organisation, 2002.
Antimicrobial resistance-An overlooked adverse event, vol.74, 2017. ,
, Promoting rational use of medicines: Core components-WHO, Policy Perspectives on Medicines, issue.5, 2002.
Irrational Use of Medicines-A Summary of Key Concepts, Pharmacy, vol.4, p.35, 2016. ,
Assessing prescriber's awareness of essential medicine list, hospital drug formulary and utilization of standard treatment guidelines in a tertiary healthcare facility in North-Central Nigeria, Alexandria J Med, vol.54, pp.81-84, 2018. ,
Studies of Drug Utilization, pp.377-401, 2012. ,
, World Health Organisation. WHO drug use in health facilites, 1993.
Drug use profile in a Nigerian city hospital, Pharmacoepidemiol Drug Saf, vol.6, pp.319-324, 1997. ,
DOI : 10.1002/(sici)1099-1557(199709/10)6:5<319::aid-pds307>3.0.co;2-u
Pattern of prescription drug use in Nigerian army hospitals, Ann Afr Med, vol.9, pp.152-160, 2010. ,
The Development of Reference Values for the WHO Health Facility Core Prescribing Indicators, West Afr J Pharmacol Drug Res, vol.18, pp.6-11, 2001. ,
An evaluation of doctors' prescribing performance in Nigeria, Pakistan J Med Sci, vol.25, pp.533-538, 2009. ,
Assessment of drug use pattern using WHO prescribing indicators at Hawassa University teaching and referral hospital, south Ethiopia: a cross-sectional study, BMC Health Serv Res, vol.13, p.170, 2013. ,
Drug prescribing pattern in three levels of health care facilities in the north and central senatorial districts of Edo State, Nigeria, Int J Herbs Pharmacol Res, vol.4, pp.46-57, 2015. ,
Evaluation of prescription pattern and patients ' opinion on healthcare practices in selected primary healthcare facilities in Ibadan , South-Western Nigeria, Afri Heal Sci, vol.15, pp.1318-1329, 2015. ,
, WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment, 2017.
, Federal Ministry of Health, Essential Medicines List, 2010.
Physicians' prescribing behaviour in two tertiary health care facilities in north-western Nigeria --Analysis of 518 prescriptions, Sahel Med J, vol.7, pp.115-118, 2004. ,
Review of Morbidity Profiles and Drug Prescribing Patterns of a University Clinic in North-Western Nigeria, Int J Med Med Sci, vol.1, pp.107-115, 2014. ,
Evaluation of drug utilization patterns and patient care practices, West African J Pharm, vol.22, pp.36-41, 2011. ,
Evaluation of rational drug use based on World Health Organization core drug use indicators in selected public hospitals of eastern Ethiopia: a cross sectional study, BMC Health Serv Res, vol.17, p.161, 2017. ,
Effect of promotional strategies of pharmaceutical companies on doctors ,
, Koruyucu Hekim Bul, vol.9, pp.1-6, 2010.
Medication errors: prescribing faults and prescription errors, Br J Clin Pharmacol, vol.67, pp.624-628, 2009. ,
DOI : 10.1111/j.1365-2125.2009.03425.x
URL : https://bpspubs.onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2125.2009.03425.x
Drug prescription pattern in a Nigerian Tertiary hospital, Trop J Pharm Res, vol.11, pp.146-152, 2012. ,
Drug Use pattern with standard indicators in Jos University Hospital Nigeria, West African J Pharm, vol.24, pp.88-93, 2013. ,
Assessment of drug use pattern using World Health Organization prescribing indicators in a tertiary care hospital in Mangalore: A crosssectional study, Natl J Physiol Pharm Pharmacol, vol.7, p.1, 2017. ,
The burden of non-communicable diseases in Nigeria; in the context of globalization, Ann Afr Med, vol.13, pp.1-10, 2014. ,
, Federal Ministry of Health. National antimalarial treatment policy, 2005.
Impact of an educational intervention on the prescribing of antimalarials at the University of Benin Teaching Hospital, Int J Heal Res, vol.4, pp.117-122, 2011. ,
Evaluation of antimalarial drugs usage according to WHO prescribing indicators in a tertiary health facility in Maiduguri, Northeastern Nigeria, Port Harcourt Med J, vol.11, p.67, 2017. ,
, Federal Republic of Nigeria. National Drug Formulary and Essential drug list act, vol.43, 1989.
Drug utilization patterns in the global context: A systematic review, Heal Policy Technol, vol.6, pp.457-470, 2017. ,
Transplantation for Acute Liver Failure in Patients Exposed to NSAIDs or Paracetamol (Acetaminophen), Drug Saf, vol.36, pp.135-144, 2013. ,
DOI : 10.1007/s40264-012-0013-7
URL : https://link.springer.com/content/pdf/10.1007%2Fs40264-012-0013-7.pdf
, World Health Organization. The Importance of Pharmacovigilance, Safety Monitoring of Medicinal Products. Geneva: World Health Organisation, 2002.
Pharmacovigilance in perspective, Drug Saf, vol.21, pp.429-447, 1999. ,
Antimicrobial resistance-An overlooked adverse event, vol.74, 2017. ,
, World Health Organization-Uppsala Monitoring Centre. Uppsala reports, 2014.
Under-Reporting of Adverse Drug Reactions, Drug Saf, vol.29, pp.385-396, 2006. ,
Under-reporting of adverse drug reactions in general practice, Br J Clin Pharmacol, vol.43, pp.177-81, 1997. ,
Determinants of Under-reporting of adverse drug reactions-A systematic review, Drug Saf, vol.32, pp.19-31, 2009. ,
Pharmacovigilance in Nigeria: An Overview, Pharmaceut Med, vol.30, pp.87-94, 2016. ,
DOI : 10.1007/s40290-015-0133-3
Adverse drug reactions reporting by physicians in Ibadan, Nigeria. Pharmacoepidemiol Drug Saf, vol.17, pp.517-539, 2008. ,
Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in, BMC Clin Pharmacol, vol.9, p.14, 2009. ,
Knowledge, attitude and practice of adverse drug reaction reporting among healthcare workers in a tertiary centre in Northern Nigeria, Trop J Pharm Res, vol.10, pp.235-242, 2011. ,
Knowledge and attitudes of physicians relating to reporting of adverse drug reactions in Sokoto, north-western Nigeria, Ann Afr Med, vol.10, pp.13-21, 2011. ,
Adverse drug reaction reporting among healthcare workers at a Nigerian Tertiary Hospital: a comparative cross-sectional survey of health care professionals, Glob Res J Med Sci, vol.2, pp.32-37, 2012. ,
Health workers and hospital patients knowledge of Pharmacovigilance in Sokoto, Niger J Pharm Sci, vol.11, pp.31-40, 2012. ,
, National Pharmacovigilance Centre (NPC) NAFDAC. Safety of medicines in Nigeria: a guide for detecting and reporting adverse drug reactions. NAFDAC-NPC-NIG, 2004.
Sample size calculation, Statistical Guide for Research Grant Application, pp.37-44, 2012. ,
An educational intervention to improve physician reporting of adverse drug reactions: A cluster-randomized controlled trial, JAMA, vol.296, pp.1086-1093, 2006. ,
Attitudes among hospital physicians to the reporting of adverse drug reactions in Sweden, Eur J Clin Pharmacol, vol.65, pp.43-46, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00477927
Attitudinal survey of voluntary reporting of adverse drug reactions, Br J Clin Pharmacol, vol.48, pp.623-630, 1999. ,
Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom, Br J Clin Pharmacol, vol.39, pp.223-229, 1995. ,
attitude and perception/practices (KAP) of medical practitioners in India towards adverse drug reaction (ADR) reporting ,
, Perspect Clin Res, vol.3, p.90, 2012.
Awareness, Attitude, and Practice of Pharmacovigilance among Health Care Professionals in Nigeria: Survey in a Teaching Hospital, Int J Hosp Res, vol.3, pp.99-108, 2013. ,
Adverse Drug Reaction reporting by different categories of healthcare workers in Nnewi, Nigeria: awareness, knowledge and attitudes, Br J Med Med Res, vol.7, pp.932-941, 2015. ,
Pharmacovigilance activities in 55 low-and middle-income countries: A questionnaire-based analysis, Drug Saf, vol.33, pp.689-703, 2010. ,
Specific features of medicines safety and pharmacovigilance in Africa, Ther Adv Drug Saf, vol.3, pp.25-34, 2012. ,
Adverse drug reaction reporting among health care workers at Mulago National Referral and Teaching hospital in Uganda, Afr Health Sci, vol.15, pp.1308-1317, 2015. ,
Attitude and Practice of Health Professionals Towards Adverse Drug Reactions Reporting, Eur J Pharm Med Res, vol.3, pp.12-21, 2016. ,
Thalidomide-induced teratogenesis: History and mechanisms, Birth Defects Res Part C Embryo Today Rev, vol.105, pp.140-156, 2015. ,
Recognition and reporting of suspected adverse drug reactions by surveyed healthcare professionals in Uganda: key determinants, BMJ Open, vol.4, p.5869, 2014. ,
Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study, Fundam Clin Pharmacol, vol.29, pp.106-111, 2015. ,
Improvement of knowledge, attitude and perception of healthcare workers about ADR, a pre-and post-clinical pharmacists' interventional study, BMJ Open, vol.2, pp.367-000367, 2012. ,
Fourrier-Réglat A. Knowledge, attitude and practice of health professionals towards adverse drug reactions reporting, Eur J Pharm Med Res, vol.3, pp.12-21, 2016. ,
References 1. World Health Organization. The importance of pharmacovigilance-Safety monitoring of medicinal products, Geneva: World Health Organisation, vol.36, pp.317-328, 2002. ,
Fourrier-Réglat A. Knowledge, attitude and practice of health professionals towards adverse drug reactions reporting, Eur J Pharm Med Res, vol.3, pp.12-21, 2016. ,
Specific features of medicines safety and pharmacovigilance in Africa, Ther Adv Drug Saf, vol.3, pp.25-34, 2012. ,
, Federal Ministry of Health. National drug policy, 2005.
, Federal Ministry of Health. Nigerian National pharmacovigilance policy and implementation framework, 2012.
, National Pharmacovigilance Centre (NPC) NAFDAC. Introducing the PVG/FDIC newsletter, Pharmacovigilance/FDIC newsletter, vol.I, pp.42-43, 2007.
Pharmacovigilance in Nigeria: An Overview, Pharmaceut Med, vol.30, pp.87-94, 2016. ,
DOI : 10.1007/s40290-015-0133-3
Knowledge, attitude and practice of adverse drug reaction reporting among healthcare workers in a tertiary centre in Northern Nigeria, Trop J Pharm Res, vol.10, pp.235-242, 2011. ,
Adverse drug reaction reporting among healthcare workers at a Nigerian Tertiary Hospital: a comparative cross-sectional survey of health care professionals, Glob Res J Med Sci, vol.2, pp.32-37, 2012. ,
Awareness, Attitude, and Practice of Pharmacovigilance among Health Care Professionals in Nigeria: Survey in a Teaching Hospital, Int J Hosp Res, vol.3, pp.99-108, 2013. ,
, National Agency for Food and Drug Administration And Control{NAFDAC}. Safety of medicines in Nigeria: a guide for detecting and reporting adverse drug reactions, NAFDAC-NPC-NIG, 2004.
Ongoing Challenges in Pharmacovigilance, Drug Saf, vol.37, pp.1-8, 2014. ,
Impact of training on Nigerian healthcare professionals' knowledge and practice of pharmacovigilance, Int J Risk Saf Med, vol.25, pp.219-227, 2013. ,
An educational intervention's effect on healthcare professionals' attitudes towards pharmacovigilance, Australas Med J, vol.7, pp.478-489, 2014. ,
DOI : 10.4066/amj.2014.2235
URL : https://doi.org/10.4066/amj.2014.2235
An impact of educational interventions on reporting of adverse drug reactions, Int J Pharm, vol.5, pp.485-492, 2015. ,
The impact of the educational intervention on knowledge, attitude, and practice of pharmacovigilance toward adverse drug reactions reporting among Health-care Professionals in a tertiary care hospital in South India, J Nat Sci Biol Med, vol.8, pp.203-209, 2017. ,
Effectiveness of pharmacovigilance: multifaceted educational intervention related to the knowledge, skills and attitudes of multidisciplinary hospital staff, Clinics (Sao Paulo), vol.72, pp.51-57, 2017. ,
Research designs for studies evaluating the effectiveness of change and improvement strategies, Qual Saf Heal Care, vol.12, pp.47-52, 2003. ,
Use of mobile phone text message reminders in health care services: a narrative literature review, J Med Internet Res, vol.16, p.222, 2014. ,
Methods for Evaluating Organisationor Area-Based Health Interventions, The Advanced Handbook of Methods in Evidence Based Healthcare, pp.295-313, 2001. ,
, Field Trials of Health Interventions: A Toolbox, 2015.
An educational intervention to improve physician reporting of adverse drug reactions: A cluster-randomized controlled trial, JAMA, vol.296, pp.1086-1093, 2006. ,
Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes?, JAMA, vol.282, pp.867-874, 1999. ,
, International drug monitoring: the role of national centres, 1972.
Adverse drug reactions: definitions, diagnosis, and management, Lancet, vol.356, pp.1255-1264, 2000. ,
Causal or casual? The role of causality assessment in pharmacovigilance, Drug Saf, vol.17, pp.374-89, 1997. ,
attitude and perception/practices (KAP) of medical practitioners in India towards adverse drug reaction (ADR) reporting ,
, Perspect Clin Res, vol.3, pp.90-94, 2012.
Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in, BMC Clin Pharmacol, vol.9, p.14, 2009. ,
Determinants of Under-reporting of adverse drug reactions-A systematic review, Drug Saf, vol.32, pp.19-31, 2009. ,
Knowledge and attitudes of physicians relating to reporting of adverse drug reactions in Sokoto, north-western Nigeria, Ann Afr Med, vol.10, pp.13-21, 2011. ,
Attitudes among hospital physicians to the reporting of adverse drug reactions in Sweden, Eur J Clin Pharmacol, vol.65, pp.43-46, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00477927
Attitudinal survey of voluntary reporting of adverse drug reactions, Br J Clin Pharmacol, vol.48, pp.623-630, 1999. ,
Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom, Br J Clin Pharmacol, vol.39, pp.223-229, 1995. ,
Health workers and hospital patients knowledge of Pharmacovigilance in Sokoto, Niger J Pharm Sci, vol.11, pp.31-40, 2012. ,
, Centers for Disease Control and Prevention and US Department of Health and Human Services. CDC -Epi Info TM, vol.7, issue.6, 2008.
Effect of An Educational Intervention to Improve Adverse Drug Reaction Reporting in Physicians: A Cluster Randomized Controlled Trial, Drug Saf, vol.38, pp.189-196, 2014. ,
Impact of Educational Interventions on Adverse Drug Events Reporting, Int J Technol Assess Health Care, vol.29, pp.410-417, 2013. ,
Recognition and reporting of suspected adverse drug reactions by surveyed healthcare professionals in Uganda: key determinants, BMJ Open, vol.4, p.5869, 2014. ,
Effect of educational intervention on healthcare providers knowledge and perception towards pharmacovigilance: A tertiary teaching hospital experience, Saudi Pharm J, vol.26, pp.611-616, 2018. ,
Health Professionals' Knowledge, Attitudes and Practices about Pharmacovigilance in India: A Systematic Review and Meta-Analysis, PLoS One, vol.11, p.152221, 2016. ,
Medication errors among health professionals in Nigeria: A national survey, Int J Risk Saf Med, vol.28, pp.77-91, 2016. ,
Pharmacovigilance Programme of India: Recent developments and future perspectives, Indian J Pharmacol, vol.48, pp.624-628, 2016. ,
Adverse drug reactions (ADRS) reporting: awareness and reasons of under-reporting among health care professionals, a challenge for pharmacists, Springerplus, vol.5, p.1778, 2016. ,
Knowledge, attitude and practices of pharmacovigilance and adverse drug reaction reporting among pharmacists working in secondary and tertiary governmental hospitals in Kuwait, Saudi Pharm J, vol.25, pp.830-837, 2017. ,
Developing and evaluating complex interventions: the new Medical Research Council guidance, BMJ, vol.337, p.1655, 2008. ,
Adverse drug reaction reporting by doctors in a developing country: a case study from Ghana, Ghana Med J, vol.48, pp.189-93, 2014. ,
Promoting adverse drug reaction reporting: comparison of different approaches, Rev Saude Publica, vol.50, p.14, 2016. ,
Pharmacovigilance in resource-limited countries, Expert Rev Clin Pharmacol, vol.8, pp.449-460, 2015. ,
, World Health Organization. WHO pharmacovigilance indicators: A practical manual for the assessment of pharmacovigilance systems, Geneva: World Health Organisation, 2015.
Issues in the design and interpretation of studies to evaluate the impact of community-based interventions, Trop Med Int Heal, vol.2, pp.1022-1029, 1997. ,
, References 1. WHO. International drug monitoring: the role of national centres, 1972.
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients, BMJ, vol.329, pp.15-24, 2004. ,
Incidence of Adverse Drug Reactions in Hospitalized Patients, JAMA, vol.279, p.1200, 1998. ,
Clinical and economic burden of adverse drug reactions, J Pharmacol Pharmacother, vol.4, pp.73-77, 2013. ,
Pharmacovigilance in Nigeria: An Overview, Pharmaceut Med, vol.30, pp.87-94, 2016. ,
The past, present and perhaps future of pharmacovigilance: Homage to Folke Sjoqvist, Eur J Clin Pharmacol, vol.69, 2013. ,
, World Health Organization. Safety Monitoring of Medicinal Products: Guidelines for setting up and running a Pharmacovigilance Centre, 2000.
Under-Reporting of Adverse Drug Reactions, Drug Saf, vol.29, pp.385-396, 2006. ,
Global patterns of adverse drug reactions over a decade-Analyses of spontaneous reports to Vigibase, Drug Saf, vol.35, pp.1171-1182, 2012. ,
Specific features of medicines safety and pharmacovigilance in Africa, Ther Adv Drug Saf, vol.3, pp.25-34, 2012. ,
Adverse reactions to fluoroquinolones in the Nigerian population: an audit of reports submitted to the National Pharmacovigilance Centre from, Pharmacol Res Perspect, vol.5, p.297, 2004. ,
Adverse drug reaction reporting among healthcare workers at a Nigerian Tertiary Hospital: a comparative cross-sectional survey of health care professionals, Glob Res J Med Sci, vol.2, pp.32-37, 2012. ,
Awareness, Attitude, and Practice of Pharmacovigilance among Health Care Professionals in Nigeria: Survey in a Teaching Hospital, Int J Hosp Res, vol.3, pp.99-108, 2013. ,
Adverse Drug Reaction reporting by different categories of healthcare workers in Nnewi, Nigeria: awareness, knowledge and attitudes, Br J Med Med Res, vol.7, pp.932-941, 2015. ,
Determinants of Under-reporting of adverse drug reactions-A systematic review, Drug Saf, vol.32, pp.19-31, 2009. ,
Spontaneous reporting of paediatric adverse drug reactions in a Nigerian tertiary health centre -any relationship to severity ?, Int J Pharm Sci Invent, vol.2, pp.5-11, 2013. ,
Adverse Drug Reactions Amongst Adult Patients Admitted in Lagos State University Teaching Hospital Lagos, Curr Drug Saf, vol.10, pp.136-144, 2015. ,
Strategies to Improve Adverse Drug Reaction Reporting: A Critical and Systematic Review, Drug Saf, vol.36, pp.317-328, 2013. ,
An impact of educational interventions on reporting of adverse drug reactions, Int J Pharm, vol.5, pp.485-492, 2015. ,
Impact of training on Nigerian healthcare professionals' knowledge and practice of pharmacovigilance, Int J Risk Saf Med, vol.25, pp.219-227, 2013. ,
Nurses' reporting of suspect adverse drug reactions: a mixed-methods study, Ann Ist Super Sanita, vol.51, pp.277-283, 2015. ,
Promoting adverse drug reaction reporting: comparison of different approaches, Rev Saude Publica, vol.50, p.14, 2016. ,
Effectiveness of pharmacovigilance: multifaceted educational intervention related to the knowledge, skills and attitudes of multidisciplinary hospital staff, Clinics (Sao Paulo), vol.72, pp.51-57, 2017. ,
Educational intervention to improve physician reporting of adverse drug reactions (ADRs) in a primary care setting in complementary and alternative medicine, BMC Public Health, vol.9, p.274, 2009. ,
, Field Trials of Health Interventions: A Toolbox, 2015.
Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes?, JAMA, vol.282, pp.867-874, 1999. ,
An educational intervention to improve physician reporting of adverse drug reactions: A cluster-randomized controlled trial, JAMA, vol.296, pp.1086-1093, 2006. ,
Research designs for studies evaluating the effectiveness of change and improvement strategies, Qual Saf Heal Care, vol.12, pp.47-52, 2003. ,
, World Health Organization. The importance of pharmacovigilance-Safety monitoring of medicinal products. Geneva: World Health Organisation, 2002.
, National Agency for Food and Drug Administration And Control{NAFDAC}. Safety of medicines in Nigeria: a guide for detecting and reporting adverse drug reactions, NAFDAC-NPC-NIG, 2004.
Adverse drug reactions: definitions, diagnosis, and management, Lancet, vol.356, pp.1255-1264, 2000. ,
DOI : 10.1016/s0140-6736(00)02799-9
Causal or casual? The role of causality assessment in pharmacovigilance, Drug Saf, vol.17, pp.374-89, 1997. ,
, Harmonised Tripartite Guideline: Clinical Safety Data Management: Definitions and Standards for Expedited Reporting E2a, 1994.
, WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment, 2017.
, The use of the WHO-UMC system for standardised case causality assessment, 2012.
A method for estimating the probability of adverse drug reactions, Clin Pharmacol Ther, vol.30, pp.239-284, 1981. ,
Improving Adverse Drug Reaction Reporting in Hospitals, Drug Saf, vol.33, pp.409-416, 2010. ,
Effect of An Educational Intervention to Improve Adverse Drug Reaction Reporting in Physicians: A Cluster Randomized Controlled Trial, Drug Saf, vol.38, pp.189-196, 2015. ,
, Report from the WHO collaborating centre for International Drug Monitoring -Activities, 2004.
Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: Analysis of 48 cohort studies, Br J Clin Pharmacol, vol.46, pp.505-511, 1998. ,
Adverse Drug Events in the Outpatient Setting: An 11-Yar National Analysis, Pharmacoepidemiol Drug Saf, vol.19, pp.901-910, 2011. ,
Why the communicable/non-communicable disease dichotomy is problematic for public health control strategies: Implications of multimorbidity for health systems in an era of health transition, Int Health, vol.7, pp.390-399, 2015. ,
Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®, Drug Saf, vol.39, pp.335-345, 2016. ,
Adverse Drug Reaction reports for cardiometabolic drugs from sub-Saharan Africa: a study in VigiBase, Trop Med Int Heal, vol.20, pp.797-806, 2015. ,
Angiotensin converting Enzyme Inhibitors associated cough a prospective evaluation in hypertensives, Ann Afr Med, vol.4, pp.118-121, 2005. ,
A profile of adverse effects of antihypertensive medicines in a tertiary care clinic in Nigeria, Ann Afr Med, vol.16, pp.114-119, 2017. ,
Drug prescription pattern in a Nigerian Tertiary hospital, Trop J Pharm Res, vol.11, pp.146-152, 2012. ,
Evaluation of drug use pattern in Lulu Brigg's Health Centre, University of Port Harcourt, Nigeria using WHO prescribing indicators, The Pharmainnovation J, vol.6, pp.506-510, 2017. ,
Africa's opioid crisis, Lancet, vol.391, pp.1982-1983, 2018. ,
, Restricting Use Of Codeine And Tramadol In Children, Recommending Against Use In Breastfeeding Women. News, 2017.
Adverse drug reactions and organ damage: The skin, Eur J Intern Med, vol.28, pp.17-24, 2016. ,
Awareness, attitude and practiceof pharmacovigilance among health care professionals in Nigeria: Survey in a Teaching Hospital, Int J Hosp Res, vol.2, pp.99-108, 2013. ,
Knowledge, attitude and practices of pharmacovigilance and adverse drug reaction reporting among pharmacists working in secondary and tertiary governmental hospitals in Kuwait, Saudi Pharm J, vol.25, pp.830-837, 2017. ,
VigiGrade: A tool to identify welldocumented individual case reports and highlight systematic data quality issues, Drug Saf, vol.37, pp.65-77, 2014. ,
Data Quality Management in Pharmacovigilance, Drug Saf, vol.27, pp.857-870, 2004. ,
Evaluation of Completeness of Suspected Adverse Drug Reaction Reports Submitted to the Mexican National Pharmacovigilance Centre, Drug Saf, vol.35, pp.837-844, 2012. ,
Lack of essential information in spontaneous reports of adverse drug reactions in Catalonia-a restraint to the potentiality for signal detection, Eur J Clin Pharmacol, vol.73, pp.751-758, 2017. ,
Unveiling the peril of substandard and falsified medicines to public health and safety in Africa: Need for all-out war to end the menace, Med Access Point Care, vol.1, pp.1596-3519, 2017. ,
Counterfeit and Sub-standard Drugs, Nigeria's Experience: Implications, Challenges, Actions and Recommendations, 2005. ,
, Federal Ministry of Health. National drug policy, 2005.
, Federal Ministry of Health. Nigerian National pharmacovigilance policy and implementation framework, 2012.
, Strengthening Pharmaceutical Systems (SPS) Program. Safety of Medicines in SubSaharan Africa: Assessment of Pharmacovigilance Systems and their Performance. Arlington VA: US Agency for International Development, 2011.
, Promoting rational use of medicines: Core components-WHO, Policy Perspectives on Medicines, issue.5, 2002.
Medication use practices and inspection of returned pills during follow-up attendance at a tertiary care hypertension clinic in Nigeria, Sahel Med J, vol.21, pp.128-164, 2018. ,
Clinical and economic burden of adverse drug reactions, J Pharmacol Pharmacother, vol.4, pp.73-80, 2013. ,
, Nigeria hypertension Society Guidelines committee, 2005.
Are They Safe?, Adv Pharm Bull, vol.6, pp.467-477, 2016. ,
The Development of Reference Values for the WHO Health Facility Core Prescribing Indicators, West Afr J Pharmacol Drug Res, vol.18, pp.6-11, 2001. ,
, Federal Ministry of Health. National antimalarial treatment policy, 2005.
, Federal Ministry of Health. Standard Treatment Guideline, Federal Ministry of Health, 2008.
Adverse effects of analgesics commonly used by older adults with osteoarthritis: focus on non-opioid and opioid analgesics, Am J Geriatr Pharmacother, vol.10, pp.331-373, 2012. ,
Transplantation for Acute Liver Failure in Patients Exposed to NSAIDs or Paracetamol (Acetaminophen), Drug Saf, vol.36, pp.135-144, 2013. ,
Upper gastrointestinal bleeding associated with antiplatelet drugs, Aliment Pharmacol Ther, vol.23, pp.235-242, 2006. ,
A prospective study on Adverse Drug Reactions of antibiotics in a tertiary care hospital, Saudi Pharm J, vol.22, pp.303-308, 2014. ,
Adverse drug reactions reporting by physicians in Ibadan, Nigeria. Pharmacoepidemiol Drug Saf, vol.17, pp.517-539, 2008. ,
Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in, BMC Clin Pharmacol, vol.9, p.14, 2009. ,
Knowledge and attitudes of physicians relating to reporting of adverse drug reactions in Sokoto, north-western Nigeria, Ann Afr Med, vol.10, pp.13-21, 2011. ,
Knowledge, attitude and practice of adverse drug reaction reporting among healthcare workers in a tertiary centre in Northern Nigeria, Trop J Pharm Res, vol.10, pp.235-242, 2011. ,
Adverse drug reaction reporting among healthcare workers at a Nigerian Tertiary Hospital: a comparative cross-sectional survey of health care professionals, Glob Res J Med Sci, vol.2, pp.32-37, 2012. ,
Health workers and hospital patients knowledge of Pharmacovigilance in Sokoto, Niger J Pharm Sci, vol.11, pp.31-40, 2012. ,
Medication errors among health professionals in Nigeria: A national survey, Int J Risk Saf Med, vol.28, pp.77-91, 2016. ,
Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom, Br J Clin Pharmacol, vol.39, pp.223-229, 1995. ,
Attitudes among healthcare professionals to the reporting of adverse drug reactions in Nepal, BMC Pharmacol Toxicol, vol.14, p.16, 2013. ,
Adverse drug reaction reporting among health care workers at Mulago National Referral and Teaching hospital in Uganda ,
, Afr Health Sci, vol.15, pp.1308-1325, 2015.
Determinants of Under-reporting of adverse drug reactions-A systematic review, Drug Saf, vol.32, pp.19-31, 2009. ,
An educational intervention to improve nurses' knowledge, attitude, and practice toward reporting of adverse drug reactions, Iran J Nurs Midwifery Res, vol.19, pp.1-6, 2014. ,
An evaluation of knowledge of pharmacovigilance among nurses and midwives in Turkey, Indian J Pharmacol, vol.45, pp.616-618, 2013. ,
Nurses' reporting of suspect adverse drug reactions: a mixed-methods study, Ann Ist Super Sanita, vol.51, pp.277-283, 2015. ,
Teaching Pharmacovigilance: the WHOISoP Core Elements of a Comprehensive Modular Curriculum, Drug Saf, vol.37, pp.743-759, 2014. ,
Attitudes to adverse drug reaction reporting in the Northern Region, Br J Clin Pharmacol, vol.34, pp.421-427, 1992. ,
Improving Monitoring and Reporting of Adverse Drug Reactions (ADRs) in HIV positive patients on Antiretroviral Therapy (ART) in Nigeria, J basic Clin Pharm, vol.3, pp.299-313, 2012. ,
Research designs for studies evaluating the effectiveness of change and improvement strategies, Qual Saf Heal Care, vol.12, pp.47-52, 2003. ,
From best evidence to best practice: Effective implementation of change in patients' care, Lancet, vol.362, pp.1225-1230, 2003. ,
Perceived barriers to reporting adverse drug events in hospitals: a qualitative study using theoretical domains framework approach, Implement Sci, vol.10, p.110, 2015. ,
Effectiveness of pharmacovigilance: multifaceted edu-cational intervention related to the knowledge, skills and attitudes of multidisciplinary hospital staff, Clincal Sci, vol.72, pp.51-57, 2017. ,
Design effect in multicenter studies: gain or loss of power, BMC Med Res Methodol, vol.9, p.39, 2009. ,
Use of mobile phone text message reminders in health care services: a narrative literature review, J Med Internet Res, vol.16, p.222, 2014. ,
Contamination in trials of educational interventions, Health Technol Assess (Rockv, p.11 ,
Issues in the design and interpretation of studies to evaluate the impact of community-based interventions, Trop Med Int Heal, vol.2, pp.1022-1029, 1997. ,
Drug-Related Morbidity and Mortality, Arch Intern Med, vol.155, p.1949, 1995. ,
Epidemiology of Adverse Drug Reactions in Europe: A Review of Recent Observational Studies, Drug Saf, vol.38, pp.437-453, 2015. ,
The burden of adverse drug events, Br J Clin Pharmacol, vol.80, pp.785-787, 2015. ,
Pharmacogenetics and adverse drug reactions, Lancet, vol.356, pp.1667-71, 2000. ,
Pharmacogenomics-Guided Approaches to Avoiding Adverse Drug Reactions, Clin Pharmacol Biopharm, vol.01, pp.1-5, 2012. ,
Data Quality Management in Pharmacovigilance, Drug Saf, vol.27, pp.857-870, 2004. ,
An estimate of the prevalence of hypertension in Nigeria, J Hypertens, vol.33, pp.230-242, 2015. ,
Drug Side Effect Symptoms and Adherence to Antihypertensive Medication, Am J Hypertens, vol.29, pp.772-779, 2016. ,
DOI : 10.1093/ajh/hpv185
URL : https://academic.oup.com/ajh/article-pdf/29/6/772/24328711/hpv185.pdf
Systematic collection of patient-reported adverse drug reactions: a path to patient-centred pharmacovigilance, Drug Saf, vol.36, pp.277-285, 2013. ,
The Quality of Clinical Information in Adverse Drug Reaction Reports by Patients and Healthcare Professionals: A Retrospective Comparative Analysis, Drug Saf, vol.40, pp.607-614, 2017. ,
Patient-centered pharmacovigilance: A review, Trop J Pharm Res, vol.17, p.179, 2018. ,
Safety and tolerability profile of Artemisinin-based antimalarial combination therapy in adult patients in Benin city, Nigeria. West Afr J Pharmacol Drug Res, vol.29, pp.25-29, 2014. ,
Angiotensin converting Enzyme Inhibitors associated cough a prospective evaluation in hypertensives, Ann Afr Med, vol.4, pp.118-121, 2005. ,
,
Multiple options can be ticked) a. Result from the pharmacological actions of the drug ,
, ADR reports should be submitted if the drug is (Multiple options can be ticked) a. A newly marketed medicine Yes
, An established medicine and vaccine Yes
, Misused or used with error Yes
, ADRs should be reported only if they are: (Multiple options can be ticked) a. New Yes
, Who should report an ADR? (Multiple options can be ticked) a. Medical doctors Yes
, Are you aware of the existence of south-south zonal pharmacovigilance centre? Yes
, ???????????? 10. Are you aware that the Nigerian National Pharmacovigilance Centre has edited an ADR reporting form (yellow form) for reporting ADRs? Yes
, What are the important elements in the ADR reporting form (yellow form) in reporting an ADR, vol.12
, If yes, Why? List the most likely reasons
,
, Do you feel you should report all ADRS even when you are not sure it is drug related? Yes
, think ADRs reporting should be made mandatory for all health care workers in Nigeria? Yes
Drug utilisation pattern in South-South Nigeria using the WHO Core drug prescribing indicators, 2018. ,
Attitude and Practice of health professionals regarding Pharmacovigilance in South-South Nigeria. Submitted to Pharmacoepidemiology and Drug Safety, 2018. ,
Educational intervention to improve the knowledge, attitude and practice of Health Care Professionals regarding pharmacovigilance in South-South Nigeria. Submitted to Therapeutic Advances in Drug Safety, 2018. ,
Impact of an educational intervention on adverse drug reaction reporting in tertiary hospitals in SouthSouth Nigeria. Submitted to Expert Opinion on Drug Safety, 2018. ,
Clinical Pharmacology in Nigeria: the BeninCity experience, Pharmacology Matters, vol.7, issue.2, pp.11-12, 2014. ,
Self-reported physical activity levels in hypertensive patients attending the medical out-patient clinic of the University of Benin Teaching Hospital, West African Journal of Pharmacology and Drug Research, vol.29, pp.30-36, 2014. ,
A Profile of Adverse Effects of Antihypertensive Medicines in a Tertiary Care Clinic in Nigeria, Annals of African Medicine, vol.16, issue.3, pp.114-119, 2017. ,
Sources of information on the use of medicines utilized by resident doctors in a tertiary health care facility in Nigeria, Highland Medical Research Journal, vol.17, issue.2, pp.81-85, 2017. ,
The internet as a source of drug information: A profile of utilization by junior hospital doctors in a Nigerian teaching hospital, Annals of Biomedical Science, vol.16, issue.2, pp.226-233, 2017. ,
Dietary habits of hypertensive patients in a tertiary hypertension clinic in southern Nigeria, Journal of Medicine and Biomedical Research, vol.15, issue.2, pp.23-33, 2016. ,
Antihypertensive medicines prescriptions before and after the Nigeria Hypertension Society guidelines and prescriber's awareness of the guideline, Nigerian Medical Journal, vol.58, issue.3, pp.107-113, 2017. ,
Management of snakebite victims using low dose antisnake venom in a tertiary hospital in Southern Nigeria: A 5-year retrospective study, Research Journal of Health Sciences, vol.6, issue.2, pp.82-89, 2018. ,
Medication use practices and inspection of returned pills during follow up attendance at a tertiary care hypertension clinic in Nigeria, Sahel Medical Journal, vol.21, pp.128-164, 2018. ,